Page 71 - วารสารการแพทย์แผนไทย ปีที่ 21 ฉบับที่ 2

J Thai Trad Alt Med Vol. 21 No. 2 May-Aug 2023 287

กลุ่ม พบว่า ไม่มีความแตกต่างกันอย่างมีนัยส�าคัญทางสถิติ (p-value > 0.05) (Table 2)

Table 2 Baseline characteristics of intervention and control groups (n = 45)

Variables Control group Intervention group p-values
(n = 13) (n = 32)
Age (years), Mean ± SD 52.15 ± 7.49 58.03 ± 9.09 0.07 ‡

Male, n (%) 11 (84.62) 25 (78.12) 1.00 †
History of liver disease, n (%)
Yes 2 (15.38) 5 (15.62) 0.36 †
Alcohol, n (%)
Yes 9 (69.23) 26 (81.25) 0.44 †
BMI, Mean ± SD 22.57 ± 2.81 22.07 ± 4.27 0.24 ‡

Body temperature (°C), Mean ± SD 36.56 ± 0.56 36.45 ± 0.38 0.15 ‡
Pulse rate (per min), Mean ± SD 82.46 ± 13.85 82.31 ± 11.77 0.98 ‡
Respiratory rate (breaths/min), Mean ± SD 19.69 ± 0.75 20.06 ± 0.80 0.11 ‡
Blood pressure, Mean ± SD
systolic (mm Hg) 121.92 ± 14.64 117.03 ± 17.37 0.38 ‡
diastolic(mm Hg) 77.84 ± 10.16 73.78 ± 11.96
Blood chemistry, Mean ± SD
Hemoglobin (g/dl) 11.92 ± 2.49 10.64 ± 2.50 0.24 ‡
Hematocrit (%) 35.91 ± 7.10 33.22 ± 5.5410 0.31 ‡
Platelet Count (mm3) 245,538.50 ± 199,354.80 ±
156,731.50 11,0846 0.31 ‡
BUN (mg%) 12.93 ± 4.92 11.58 ± 5.06 0.33 ‡
Serum Creatinine (mg%) 0.84 ± 0.18 0.96 ± 0.54 0.40 ‡
eGFR 96.48 ± 19.26 88.25 ± 16.14 0.06 ‡
Total Bilirubin (U/L) 2.025 ± 1.77 2.57 ± 3.10 0.56 ‡
Direct Bilirubin (mg%) 1.12 ± 1.44 1.14 ± 1.84 0.97 ‡
ALP (U/L) 248.66 ± 188.01 219.28 ± 136.48 0.57 ‡
AST (U/L) 119.09 ± 71.0471 131.31 ± 109.25 0.87 ‡
ALT (U/L) 72.81 ± 45.99 72.81 ± 77.85 0.48 ‡
Present Complaints
Dyspepsia (VAS), Mean ± SD 2.23 ± 0.55 2.59 ± 2.78 0.82 ‡

Appetite loss (VAS), Mean ± SD 1.38 ± 2.02 1.31 ± 2.66 0.48 ‡
Fatigue (VAS), Mean ± SD 2.69 ± 2.56 2.96 ± 3.35 0.75 ‡